TABLE 1.

PATIENT CHARACTERISTICS

Females	11/22 (50.0%)
Mean Age at time of KPro	50.0 ± 15.1 (10–81 yrs)
Race
African American	12/22 (54.5%)
Caucasian	8/22 (36.4%)
Hispanic	2/22 (9.1%)
Indications for KPro
Non-Inflammatory Dystrophies/Degenerations	8/22 (36.4%)
Corneal dystrophy (1 CHED, 1 lattice, 2 gelatinous droplike)	4/22 (18.2%)
Pseudophakic bullous keratopathy	1/22 (4.5%)
Keratoconus	1/22 (4.5%)
Iridocorneal endothelial syndrome (Chandler syndrome)	1/22 (4.5%)
Limbal stem cell deficiency	1/22 (4.5%)
Burns	5/22 (22.7%)
Chemical burn	4/22 (18.2%)
Thermal burn	1/22 (4.5%)
Autoimmune	4/22 (18.2%)
Uveitis	2/22 (9.1%)
Stevens-Johnson syndrome	2/22 (9.1%)
Infectious	3/22 (15/6%)
Herpetic keratitis	3/22 (15.6%)
Aniridia	2/22 (9.1%)
Primary KPro	7/22 (31.8%)
Secondary Kpro (following prior immunologic transplant rejection)	15/22 (68.2%)
# of Patients who had IOP-Lowering Procedures
None	6/22 (27.3%)
At Any Time	16/22 (72.7%)
Pre-KPro	5/22 (22.7%)
Concurrently	10/22 (45.5%)
Post-KPro	6/22 (27.3%)